Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


11.09.2017

3 AJNR Am J Neuroradiol
1 BMC Cancer
1 Cancer
2 Eur J Cancer
1 Int J Cancer
8 Int J Radiat Oncol Biol Phys
8 J Clin Oncol
4 J Neurooncol
1 J Neuropathol Exp Neurol
1 J Neurosurg
2 Neuro Oncol
1 Neuroradiology
1 Neurosurgery
6 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. VERBURG N, Hoefnagels FWA, Barkhof F, Boellaard R, et al
    Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis.
    AJNR Am J Neuroradiol. 2017 Sep 7. doi: 10.3174/ajnr.A5368.
    PubMed     Text format     Abstract available

  2. SHEARKHANI O, Khademi A, Eilaghi A, Hojjat SP, et al
    Detection of Volume-Changing Metastatic Brain Tumors on Longitudinal MRI Using a Semiautomated Algorithm Based on the Jacobian Operator Field.
    AJNR Am J Neuroradiol. 2017 Sep 7. doi: 10.3174/ajnr.A5352.
    PubMed     Text format     Abstract available

  3. QIU TM, Gong FY, Gong X, Wu JS, et al
    Real-Time Motor Cortex Mapping for the Safe Resection of Glioma: An Intraoperative Resting-State fMRI Study.
    AJNR Am J Neuroradiol. 2017 Sep 7. doi: 10.3174/ajnr.A5369.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. NIIBE Y, Nishimura T, Inoue T, Karasawa K, et al
    Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    BMC Cancer. 2016;16:659.
    PubMed     Text format     Abstract available


    Cancer


  5. Wearable medical device improves survival for glioblastoma patients.
    Cancer. 2017;123:3433.
    PubMed     Text format    


    Eur J Cancer

  6. GANDHI L, Ignatius Ou SH, Shaw AT, Barlesi F, et al
    Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria.
    Eur J Cancer. 2017;82:27-33.
    PubMed     Text format     Abstract available

  7. GATTA G, Peris-Bonet R, Visser O, Stiller C, et al
    Geographical variability in survival of European children with central nervous system tumours.
    Eur J Cancer. 2017;82:137-148.
    PubMed     Text format     Abstract available


    Int J Cancer

  8. CIAGLIA E, Laezza C, Abate M, Pisanti S, et al
    Recognition by Natural Killer cells of N6 -isopentenyladenosine-treated human glioma cell lines.
    Int J Cancer. 2017 Sep 7. doi: 10.1002/ijc.31036.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  9. SANFORD NN, Yeap BY, Larvie M, Daartz J, et al
    Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas.
    Int J Radiat Oncol Biol Phys. 2017 Jul 12. pii: S0360-3016(17)33567.
    PubMed     Text format     Abstract available

  10. KRALIK SF, Watson GA, Shih CS, Ho CY, et al
    Radiation-Induced Large Vessel Cerebral Vasculopathy in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017 Jul 12. pii: S0360-3016(17)33568.
    PubMed     Text format     Abstract available

  11. ZAWASKI JA, Sabek OM, Voicu H, Eastwood Leung HC, et al
    Effect of Brain Tumor Presence During Radiation on Tissue Toxicity: Transcriptomic and Metabolic Changes.
    Int J Radiat Oncol Biol Phys. 2017 Jul 12. pii: S0360-3016(17)33591.
    PubMed     Text format     Abstract available

  12. CHATTERJEE A, Serban M, Abdulkarim B, Panet-Raymond V, et al
    Performance of Knowledge-Based Radiation Therapy Planning for the Glioblastoma Disease Site.
    Int J Radiat Oncol Biol Phys. 2017 Jul 14. pii: S0360-3016(17)33593.
    PubMed     Text format     Abstract available

  13. CLARKE J, Neil E, Terziev R, Gutin P, et al
    Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Int J Radiat Oncol Biol Phys. 2017 Jun 30. pii: S0360-3016(17)33549.
    PubMed     Text format     Abstract available

  14. LUCAS JT JR, Cooper DA, Hwang S, Tinkle C, et al
    Prognostic Relevance of Treatment Failure Patterns in Pediatric High-Grade Glioma: Is There a Role for a Revised Failure Classification System?
    Int J Radiat Oncol Biol Phys. 2017;99:450-458.
    PubMed     Text format     Abstract available

  15. PRABHU RS, Press RH, Patel KR, Boselli DM, et al
    Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;99:459-467.
    PubMed     Text format     Abstract available

  16. CALMON R, Puget S, Varlet P, Beccaria K, et al
    Multimodal Magnetic Resonance Imaging of Treatment-Induced Changes to Diffuse Infiltrating Pontine Gliomas in Children and Correlation to Patient Progression-Free Survival.
    Int J Radiat Oncol Biol Phys. 2017;99:476-485.
    PubMed     Text format     Abstract available


    J Clin Oncol

  17. KIM DW, Tiseo M, Ahn MJ, Reckamp KL, et al
    Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.
    J Clin Oncol. 2017 May 5:JCO2016715904. doi: 10.1200/JCO.2016.71.5904.
    PubMed     Text format     Abstract available

  18. LIM SM, Kim HR, Lee JS, Lee KH, et al
    Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.
    J Clin Oncol. 2017 May 18:JCO2016713701. doi: 10.1200/JCO.2016.71.3701.
    PubMed     Text format     Abstract available

  19. WINICK N, Devidas M, Chen S, Maloney K, et al
    Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
    J Clin Oncol. 2017 May 23:JCO2016714774. doi: 10.1200/JCO.2016.71.4774.
    PubMed     Text format     Abstract available

  20. MERCHANT TE
    Current Clinical Challenges in Childhood Ependymoma: A Focused Review.
    J Clin Oncol. 2017;35:2364-2369.
    PubMed     Text format     Abstract available

  21. CAMPIAN J, Gutmann DH
    CNS Tumors in Neurofibromatosis.
    J Clin Oncol. 2017;35:2378-2385.
    PubMed     Text format     Abstract available

  22. GROMMES C, DeAngelis LM
    Primary CNS Lymphoma.
    J Clin Oncol. 2017 Jun 22:JCO2017727602. doi: 10.1200/JCO.2017.72.7602.
    PubMed     Text format     Abstract available

  23. VAN DEN BENT MJ, Smits M, Kros JM, Chang SM, et al
    Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
    J Clin Oncol. 2017;35:2394-2401.
    PubMed     Text format     Abstract available

  24. WEN PY, Chang SM, Van den Bent MJ, Vogelbaum MA, et al
    Response Assessment in Neuro-Oncology Clinical Trials.
    J Clin Oncol. 2017;35:2439-2449.
    PubMed     Text format     Abstract available


    J Neurooncol

  25. DELFANTI RL, Piccioni DE, Handwerker J, Bahrami N, et al
    Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.
    J Neurooncol. 2017 Sep 4. doi: 10.1007/s11060-017-2613.
    PubMed     Text format     Abstract available

  26. ARUN S, Ravisankar S, Vanisree AJ
    Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc.
    J Neurooncol. 2017 Sep 5. doi: 10.1007/s11060-017-2608.
    PubMed     Text format     Abstract available

  27. JOSHI S, Cooke JRN, Ellis JA, Emala CW, et al
    Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy.
    J Neurooncol. 2017 Sep 5. doi: 10.1007/s11060-017-2615.
    PubMed     Text format     Abstract available

  28. ETXANIZ O, Carrato C, de Aguirre I, Queralt C, et al
    IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
    J Neurooncol. 2017 Sep 7. doi: 10.1007/s11060-017-2570.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  29. RYALL S, Arnoldo A, Krishnatry R, Mistry M, et al
    Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System.
    J Neuropathol Exp Neurol. 2017;76:562-570.
    PubMed     Text format     Abstract available


    J Neurosurg

  30. FUJII Y, Muragaki Y, Maruyama T, Nitta M, et al
    Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    J Neurosurg. 2017 Sep 8:1-9. doi: 10.3171/2017.3.JNS162383.
    PubMed     Text format     Abstract available


    Neuro Oncol

  31. ZHANG Z, Chan AK, Ding X, Li Y, et al
    Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas.
    Neuro Oncol. 2017;19:1008-1010.
    PubMed     Text format    

  32. OKADA H, Thorne SH
    Is the immune response a friend or foe for viral therapy of glioma?
    Neuro Oncol. 2017;19:882-883.
    PubMed     Text format    


    Neuroradiology

  33. BURROWES D, Fangusaro JR, Nelson PC, Zhang B, et al
    Erratum to: Extended diffusion weighted magnetic resonance imaging with two-compartment and anomalous diffusion models for differentiation of low-grade and high-grade brain tumors in pediatric patients.
    Neuroradiology. 2017 Sep 6. doi: 10.1007/s00234-017-1918.
    PubMed     Text format    


    Neurosurgery

  34. KIM WJ, Newman WC, Amankulor NM
    Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma.
    Neurosurgery. 2017;81:N11.
    PubMed     Text format    


    PLoS One

  35. GOODS BA, Hernandez AL, Lowther DE, Lucca LE, et al
    Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.
    PLoS One. 2017;12:e0181538.
    PubMed     Text format     Abstract available

  36. FORNVIK K, Maddahi A, Persson O, Osther K, et al
    C1-inactivator is upregulated in glioblastoma.
    PLoS One. 2017;12:e0183086.
    PubMed     Text format     Abstract available

  37. CHENG B, Morales LD, Zhang Y, Mito S, et al
    Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line.
    PLoS One. 2017;12:e0184324.
    PubMed     Text format     Abstract available

  38. FELDMAN LA, Fabre MS, Grasso C, Reid D, et al
    Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas.
    PLoS One. 2017;12:e0184250.
    PubMed     Text format     Abstract available

  39. WERNECK DE CARVALHO LE, Sarraf JS, Semblano AA, Moreira MA, et al
    Central nervous system tumours profile at a referral center in the Brazilian Amazon region, 1997-2014.
    PLoS One. 2017;12:e0174439.
    PubMed     Text format     Abstract available

  40. RAMACHANDRAN RK, Sorensen MD, Aaberg-Jessen C, Hermansen SK, et al
    Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
    PLoS One. 2017;12:e0172234.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  41. ANTONIOS JP, Soto H, Everson RG, Moughon DL, et al
    Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201706689.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: